Sernova Biotherapeutics Inc. Stock: price and insider trades · Canada
Sernova Biotherapeutics Inc.: what insiders have been doing
Sernova Biotherapeutics Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. The last twelve months, up to 24 October 2026, brought 23 filings signed by 8 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (2,734 companies, median 14 filings), a count of 23 filings is above the norm.
Over the last twelve months, not one insider purchase of Sernova Biotherapeutics Inc. stock was filed. Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
- @ €0.0685Convertible DebenturesTSXSEDI:4788064
- @ €0.0935Convertible DebenturesTSXSEDI:4788063
- @ €0.0935Convertible DebenturesTSXSEDI:4788061
- @ €0.0935Convertible DebenturesTSXSEDI:4788060
- @ €0.1246Convertible DebenturesTSXSEDI:4788058
- 909,091 sharesWarrantsTSXSEDI:4788052
- @ €0.0685Convertible DebenturesTSXSEDI:4788049
- @ €0.0923Convertible DebenturesTSXSEDI:4769826
- 115,000 sharesCommon SharesTSXSEDI:4747055
- 260,000 shares@ CA$0.162.7% of flowOptionsTSXSEDI:4724422
- 228,912 shares@ CA$0.1638.9% of flowOptionsTSXSEDI:4724420
- 360,000 shares@ CA$0.1661.1% of flowOptionsTSXSEDI:4724418
- 194,229 shares@ CA$0.1642.8% of flowOptionsTSXSEDI:4724417
- 260,000 shares@ CA$0.1657.2% of flowOptionsTSXSEDI:4724415
- 173,418 shares@ CA$0.1640.0% of flowOptionsTSXSEDI:4724412
- 260,000 shares@ CA$0.1660.0% of flowOptionsTSXSEDI:4724409
- 166,482 shares@ CA$0.1639.0% of flowOptionsTSXSEDI:4724406
- 260,000 shares@ CA$0.1661.0% of flowOptionsTSXSEDI:4724405
- 26,666,667 shares@ CA$0.1572.9% of flowCommon SharesTSXSEDI:4706138
- 10,000,000 shares@ CA$0.1597.3% of flowCommon SharesTSXSEDI:4705035
- Common SharesTSXSEDI:4705018
- 229,877 shares@ CA$0.19100.0% of flowCommon SharesTSXSEDI:4705019
- 229,877 shares@ CA$0.19100.0% of flowCommon SharesTSXSEDI:4704982
- 8,000 shares@ CA$0.195100.0% of flowCommon SharesTSXSEDI:4578269
- 138,500 shares@ CA$0.19369.0% of flowCommon SharesTSXSEDI:4565049
25 of 27 declarations
About Sernova Biotherapeutics Inc.
Sernova Biotherapeutics Inc. is a biopharmaceutical company focused on developing cell therapies for chronic diseases. It is listed on the XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
